Tyra Biosciences
Sydney Borden is currently serving as the Clinical Operations Lead at Tyra Biosciences since October 2023. Prior to this role, Sydney worked at Fortrea as a Clinical Research Associate II (Oncology) from April 2023 to October 2023, following a tenure at Labcorp Drug Development as both a Clinical Research Associate I (Oncology) and an In-House Clinical Research Associate I from March 2021 to May 2023. Sydney's earlier experience includes roles as a Clinical Project Specialist and Clinical Trial Assistant at Catalyst Clinical Research, LLC from July 2019 to March 2021, and as an Emergency Medical Technician at Priority Care Ambulance from May 2018 to 2019. Sydney began a professional career with research experience as an Undergraduate Research Assistant at North Carolina State University, contributing to a five-year investigation on gardening's impact on young children's health. Sydney holds a Bachelor of Science degree in Biological Sciences with a focus on Nutrition Science from North Carolina State University, completed in 2019.
This person is not in any teams
This person is not in any offices
Tyra Biosciences
1 followers
Tyra Biosciences is targeting new pathways of acquired resistance in oncology with purpose-built drugs for the benefit of patients.